Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID‐19

BACKGROUND: Venous thromboembolism (VTE) risk is increased in patients with COVID‐19 infection. Understanding which patients are likely to develop VTE may inform pharmacologic VTE prophylaxis decision making. The hospital‐associated venous thromboembolism–Intermountain Risk Score (HA‐VTE IMRS) and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Woller, Scott C., Stevens, Scott M., Bledsoe, Joseph R., Fazili, Masarret, Lloyd, James F., Snow, Greg L., Horne, Benjamin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301476/
https://www.ncbi.nlm.nih.gov/pubmed/35873221
http://dx.doi.org/10.1002/rth2.12765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301476/
https://www.ncbi.nlm.nih.gov/pubmed/35873221
http://dx.doi.org/10.1002/rth2.12765

Ejemplares similares